8-K - Mirum Pharmaceuticals, Inc. | StockGist

Current Report Details

Event Type

Financial Results

Exhibits Only

Disclosure

Mandatory

Variant

8-K

Items Reported

2.02

Results of Operations and Financial Condition. On November 4, 2025, Mirum Pharmaceuticals, Inc. (the “Company”) issued a press release providing a corporate upd

Financial Results

9.01

Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 Press Release dated November 4, 2025 104 Cover Page Interactive Data File (embedde

Exhibits Only

Source Document

Exhibits (2)

8-K

99.1

EX-99.1